VRT.CN - Veritas Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-04-29
2018-04-29
2017-04-29
2016-04-29
Total Revenue
0
0
0
-
-
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
122
149
96
45
-
Selling General and Administrative
3,257
3,080
12,979
3,303
864
Total Operating Expenses
3,384
3,239
13,094
3,350
864
Operating Income or Loss
-3,384
-3,239
-13,094
-3,350
-864
Interest Expense
-
-
0
34
50
Total Other Income/Expenses Net
-
-8,660
-908
435
0
Income Before Tax
-12,043
-11,899
-14,002
-2,949
-914
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-12,043
-11,899
-14,002
-2,949
-914
Net Income
-12,043
-11,899
-13,863
-2,931
-1,161
Net Income available to common shareholders
-12,043
-11,899
-13,863
-2,931
-1,161
Reported EPS
Basic
-
-
-2.90
-1.00
-0.60
Diluted
-
-
-2.90
-1.00
-0.60
Weighted average shares outstanding
Basic
-
-
4,690
2,841
2,037
Diluted
-
-
4,690
2,841
2,037
EBITDA
-
-3,229
-13,983
-2,914
-864